Phage TherapyNews - Page 1

Phage therapies: Nature’s answer to combating superbugs

Cellexus is committed to supporting the development of phage therapies, which use bacteriophages to combat superbugs. Discover more here.

From wastewater to wound care: How phages are found, harvested, and used

Discover how bacteriophages are sourced, refined, and used in cutting-edge treatments to combat infections and AMR.

How phage therapy can combat the global AMR crisis

Discover how phage therapy offers a revolutionary, targeted solution to combat the global antimicrobial resistance crisis.

Phages in agriculture: Revolutionising crop protection without harmful chemicals

Discover how phages in agriculture offer a sustainable alternative to chemical pesticides by targeting harmful bacteria.

Global phage therapy market to reach $116m by 2028 amid rising AMR

Discover how the phage therapy market, valued at $116.6m by 2028, is revolutionising healthcare by addressing antibiotic resistance.

The rise of antimicrobial resistance: A global health crisis in the making

Industry can fight against this global health crisis by learning more about risks and solutions and adjusting their business practices.

Bacteriophage therapy offers hope for drug-resistant infections

Qeen Biotechnologies has provided bacteriophage therapy to treat a periprosthetic joint infection caused by an AMR pathogen. Find out more.

Phage therapy’s role in treating fracture-related infections

Fracture-related infections pose significant challenges, often exacerbated by antibiotic resistance and biofilm formation.

An in-depth overview of the science behind phage therapy

Breakthroughs in phage therapy are revolutionising treatment strategies. Learn about challenges in this evolving field of bacterial warfare.

Antimicrobial resistance: Should we be worried?

Valerie Edward-Jones provides insights into the AMR landscape and effective strategies to combat this urgent health threat.

Developing solutions to combat antibiotic resistant bacteria

Proteon Pharmaceuticals SA has established the Phage Development Platform, which is providing novel solutions to antibiotic resistance.

The social and economic consequences of antimicrobial resistance

Dr Jochen Salber, Head of the Department of Experimental Surgery at University Medical Centre Knappschaftskrankenhaus Bochum, discusses the challenges posed by antimicrobial resistance. At a...

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd